genedrive plc (AIM:GDR)
London · Delayed Price · Currency is GBP · Price in GBX 1.076
+0.126 (13.26%)
May 8, 2026, 4:24 PM GMT
genedrive Market Cap
genedrive has a market cap or net worth of 15.25 million as of May 8, 2026. Its market cap has increased by 61.65% in one year.
Market Cap
15.25M
Enterprise Value
15.37M
Revenue
1.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.08
Market Cap Chart
Since April 10, 2007, genedrive's market cap has increased from 11.67M to 15.25M, an increase of 30.70%. That is a compound annual growth rate of 1.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 15.25M | 69.31% |
| Dec 31, 2025 | 9.01M | -32.30% |
| Dec 31, 2024 | 13.31M | 33.76% |
| Dec 29, 2023 | 9.95M | -2.27% |
| Dec 30, 2022 | 10.18M | -74.34% |
| Dec 31, 2021 | 39.68M | 29.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 206.50B |
| GSK plc | 74.19B |
| Haleon | 29.76B |
| Smith & Nephew | 9.51B |
| Aptamer Group | 20.73M |
| Cambridge Cognition Holdings | 16.29M |
| Fusion Antibodies | 16.25M |
| IXICO | 14.99M |